case_images: PMC11743586_01
case_images: CT images of the chest: diffuse ground-glass opacities involving the entirety of both lung fields.
case_images: gr1.jpg
case_images: PMC11743586_01_gr1.jpg
case_images: fig1
case_images: ALK-rearranged NSCLC the patient was started first-line alectinib 600 mg twice daily. After 2 months of alectinib treatment the patient reported dyspnea and chest pain and diffuse ground-glass opacities were found in the CT scan of the chest (Fig. 1).
case_images: CT images of the chest after 3 weeks while the patient remained on corticosteroids and off alectinib, the previously ground-glass opacities were resolved.
case_images: gr2.jpg
case_images: PMC11743586_01_gr2.jpg
case_images: fig2
case_images: Three weeks after initiating steroids a CT scan of the chest showed that the ground-glass opacities were almost completely resolved without evidence of short-term tumor progression (Fig. 2).